Home › Narcolepsy › NCT06383806
Decreasing Nightmares in Adults With Narcolepsy
Imagery Rehearsal Therapy for the Treatment of Nightmares in Narcolepsy: A Pilot Randomized Controlled Trial
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
PARTICIPANTS WITH NARCOLEPSY/NIGHTMARES Inclusion Criteria: * Diagnosis of narcolepsy type 1 or narcolepsy type 2 * Nightmare frequency of ≥1 times per week * Age 18 or older * Able to speak, read, and write in English * Live in the United States * Sleep and psychiatric medications stable for ≥ 1 month and willing to keep medications stable for the duration of the study Exclusion Criteria: * Currently engaged in trauma- or sleep-related psychotherapy * Previous behavioral treatment for nightmares * Medical, psychiatric, or cognitive condition which would interfere with ability to engage in the treatment * Untreated moderate-severe sleep apnea PARTICIPANTS WHO ARE PARTNERS OF SOMEONE WITH NARCOLEPSY Inclusion Criteria: * Live with a romantic partner who meets the above criteria and has agreed to participate in the study * Age 18 or older * Able to speak, read, and write in English * Live in the United States
About the study
The purpose of this clinical trial is learn whether a behavioral (non-medication) treatment can reduce nightmares in adults with narcolepsy. All participants will receive the treatment and will complete three assessments. Half of the participants will receive the treatment after the first assessment, and half will receive it after the second assessment. Romantic partners of participants with narcolepsy will also be eligible to enroll in the study. Partners will complete three assessments but will not participate in the treatment.
What is being tested
- Imagery Rehearsal Therapy (IRT) (behavioral)
Sponsor: University of Utah · Participants: 80 · Started: Jul 1, 2026
Contact the study team
- Jennifer Mundt, PhD · Phone: 801-646-8287
Official record on ClinicalTrials.gov — NCT06383806
Locations in the U.S.
| Utah | University of Utah, Salt Lake City |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.